Classic Hodgkin Lymphoma — Trials

Classic Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

114 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 41
Recruiting: 17
Ph III recruiting: 1
Growth YoY: —
Industry share: 12%
Top sponsor: City of Hope Medical Center
Termination share: 32.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (14)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07572123	Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treatment of Chemotherapy and Autologous Stem Cell Transplant Alone for High-risk Patients With Relapsed or Refractory Hodgkin Lymphoma	not yet recruiting	Phase 2 / Phase 3	374	National Cancer Institute (NCI)NIH	0	Jul 8, 2026	clinicaltrials
NCT06617286	CD30 CAR T-cells Post AutoHSCT for Poor-risk Hodgkin Lymphoma	not yet recruiting	Phase 1 / Phase 2	21	New York Medical CollegeOTHER	1	Apr 15, 2026